首页> 外文OA文献 >In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia apparatus II and III
【2h】

In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia apparatus II and III

机译:使用美国药典设备II和III在多pH介质中体外评估结肠特异性药物递送系统(CODES™)的溶解行为

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

United States Pharmacopeia dissolution apparatus II (paddle) and III (reciprocating cylinder) coupled with automatic sampling devices and software were used to develop a testing procedure for acquiring release profiles of colon-specific drug delivery system (CODES™) drug formulations in multi-pH media using acetaminophen (APAP) as a model drug. System suitability was examined. Several important instrument parameters and formulation variables were evaluated. Release profiles in artificial gastric fluid (pH 1.2), intestinal fluid (pH 6.8), and pH 5.0 buffer were determined. As expected, the percent release of APAP from coated core tablets was highly pH dependent. A release profile exhibiting a negligible release in pH 1.2 and 6.8 buffers followed by a rapid release in pH 5.0 buffer was established. The drug release in pH 5.0 buffer increased significantly with the increase in the dip or paddle speed but was inversely related to the screen mesh observed at lower dip speeds. It was interesting to note that there was a close similarity (f2=80.6) between the release profiles at dip speed 5 dpm and paddle speed 100 rpm. In addition, the release rate was reduced significantly with the increase in acid-soluble Eudragit E coating levels, but lactulose loading showed only a negligible effect. In conclusion, the established reciprocating cylinder method at lower agitation rates can give release profiles equivalent to those for the paddle procedure for CODES™ drug pH-gradient release testing. Apparatus III was demonstrated to be more convenient and efficient than apparatus II by providing various programmable options in sampling times, agitation rates, and medium changes, which suggested that the apparatus II approach has better potential for in vitro evaluation of colon-specific drug delivery systems.
机译:美国药典溶出度仪II(桨叶)和III(往复缸)与自动采样装置和软件配合使用,开发了一种测试程序,以获取多pH值的结肠特异性药物递送系统(CODES™)药物制剂的释放曲线介质中使用对乙酰氨基酚(APAP)作为模型药物。检查系统适用性。评估了几个重要的仪器参数和配方变量。确定在人造胃液(pH 1.2),肠液(pH 6.8)和pH 5.0缓冲液中的释放曲线。正如预期的那样,包衣片剂中APAP的释放百分比高度依赖pH。建立了在pH 1.2和6.8缓冲液中释放微不足道的释放曲线,然后在pH 5.0缓冲液中快速释放。 pH 5.0缓冲液中的药物释放随着浸入速度或桨叶速度的增加而显着增加,但与以较低浸入速度观察到的筛网成反比。有趣的是,在下降速度为5 dpm和桨速度为100 rpm时,释放曲线之间存在相似性(f2 = 80.6)。另外,释放速率随酸溶性Eudragit E包衣水平的增加而显着降低,但乳果糖的负载量仅显示微不足道的效果。总之,在较低的搅拌速率下建立的往复缸方法可以提供与CODES™药物pH梯度释放测试的桨叶程序相同的释放曲线。通过在采样时间,搅拌速度和培养基变化方面提供各种可编程选项,仪器III被证明比仪器II更方便和有效,这表明仪器II的方法在体外评估结肠特异性药物递送系统方面具有更好的潜力。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号